Am J Transplant, Volume 18, Suppl 3 Archives - Page 211 of 211 - ATC Abstracts

2018 American Transplant Congress
Building a Third-Party VST Bank from Scratch- The Cincinnati Experience
A. S. Nelson,¹ D. Heyenbruch,² X. Zhu,³ S. M. Davies,¹ C. Lutzko,³ C. Bollard,⁴ P. Hanley,⁴ T. Leemhuis,² L. Danziger-Isakov,⁵ M. S. Grimley.¹
¹Bone Marrow Transplant & Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; ²Hoxworth Blood Center, Univeristy of Cincinnati, Cincinnati, OH; ³Experimental Hematology & Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; ⁴Proram for Cell Enhancement and Technologies for Immunotherapy, Children's National Health System, Washington, DC; ⁵Depatment of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
BackgroundViral infections remain a challenge to treat and significantly contribute to morbidity and mortality. Virus specific T cells (VSTs) have shown clinical efficacy, with minimal…
2018 American Transplant Congress
Precision (re)Phenotyping of Histologically Stable Kidney Transplants
D. Rychkov,¹ T. Sigdel,² M. Sirota,¹ M. Sarwal.²
¹Institute for Computational Health Sciences, UCSF, San Francisco, CA; ²Department of Surgery, UCSF, San Francisco, CA.
Background: Acute Rejection (AR) is the main cause of the renal failure within one year after transplantation (tx). Its earlier diagnosis is crucial for a…